Ameriprise Financial Inc. Has $4,622,000 Position in National Health Investors Inc. (NHI)
Ameriprise Financial Inc. increased its position in shares of National Health Investors Inc. (NYSE:NHI) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 61,540 shares of the real estate investment trust’s stock after buying an additional 288 shares during the period. Ameriprise Financial Inc. owned approximately 0.16% of National Health Investors worth $4,622,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in NHI. Societe Generale bought a new position in shares of National Health Investors during the second quarter worth about $103,000. Creative Planning increased its position in shares of National Health Investors by 2.6% in the second quarter. Creative Planning now owns 1,390 shares of the real estate investment trust’s stock worth $104,000 after buying an additional 35 shares during the last quarter. BlackRock Japan Co. Ltd increased its position in shares of National Health Investors by 1.1% in the first quarter. BlackRock Japan Co. Ltd now owns 1,809 shares of the real estate investment trust’s stock worth $120,000 after buying an additional 20 shares during the last quarter. BNP Paribas Arbitrage SA increased its position in shares of National Health Investors by 6,303.6% in the second quarter. BNP Paribas Arbitrage SA now owns 1,793 shares of the real estate investment trust’s stock worth $135,000 after buying an additional 1,765 shares during the last quarter. Finally, Navellier & Associates Inc bought a new position in shares of National Health Investors during the second quarter worth about $251,000. 67.48% of the stock is owned by institutional investors.
Shares of National Health Investors Inc. (NYSE:NHI) traded up 1.05% during mid-day trading on Monday, hitting $77.65. The company had a trading volume of 17,903 shares. The firm has a market capitalization of $3.04 billion, a P/E ratio of 17.91 and a beta of 0.61. The firm has a 50-day moving average price of $78.58 and a 200 day moving average price of $74.01. National Health Investors Inc. has a 12 month low of $54.51 and a 12 month high of $82.53.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, August 5th. The real estate investment trust reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.01. The business earned $61.20 million during the quarter, compared to the consensus estimate of $58.08 million. National Health Investors had a return on equity of 14.68% and a net margin of 69.69%. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.17 earnings per share. On average, equities research analysts forecast that National Health Investors Inc. will post $4.88 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 10th. Stockholders of record on Friday, September 30th will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.69%. The ex-dividend date of this dividend is Wednesday, September 28th. National Health Investors’s dividend payout ratio is currently 82.95%.
A number of brokerages have issued reports on NHI. Stephens began coverage on National Health Investors in a report on Wednesday, September 14th. They issued an “overweight” rating and a $84.00 price target for the company. Zacks Investment Research raised National Health Investors from a “sell” rating to a “hold” rating in a research note on Thursday, August 11th. Cantor Fitzgerald reaffirmed a “hold” rating on shares of National Health Investors in a research note on Friday, September 9th. Wells Fargo & Co. reaffirmed a “hold” rating on shares of National Health Investors in a research note on Sunday, September 4th. Finally, Mizuho upped their target price on National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research note on Monday, August 8th. Five equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $73.86.
In other news, Director Robert A. Mccabe, Jr. sold 800 shares of National Health Investors stock in a transaction on Tuesday, August 30th. The stock was sold at an average price of $80.29, for a total value of $64,232.00. Following the completion of the sale, the director now owns 10,021 shares of the company’s stock, valued at $804,586.09. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 5.74% of the stock is owned by insiders.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc. (NYSE:NHI).
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.